Boston Scientific falls after discontinuing heart device, FDA approval pursuit

ReutersMay 28, 2025 12:22 PM

Shares of medical device maker Boston Scientific BSX.N fall 2% to $103 premarket

BSX says it is discontinuing worldwide sales of its experimental heart device and will no longer seek US FDA approval in the country or other regions

Co says the decision was made due to increased regulatory requirements

Co also says it expects to meet its Q2 and FY25 sales and adjusted earnings forecast

As of last close, stock up ~19% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

TradingKey’s The Week on Wall Street: Will Inflation Stall the AI-Driven Rally?

Wall Street faces a tug-of-war between strong AI-driven earnings and rising macro risks. While tech stocks remain resilient, persistent inflation (3.3%) and Middle East tensions are fueling volatility. All eyes turn to upcoming CPI data to determine if the Fed will maintain its hawkish stance throug

Is Micron the Next Nvidia? Why the 2026 "Memory Crunch" Makes MU Stock a Top AI Buy

While there is still a risk of industry cycles, the current "Memory Crunch" has put Micron in a position of power that the company likely has never had in its 40-year history. For anyone looking to play the physical infrastructure of the future, MU stock is still a top pick for a diversified tech po

U.S. April CPI Preview: Fed May Abandon Rate Cuts Until 2026?

TradingKey - The U.S. Bureau of Labor Statistics will release the April CPI report on May 12 at 8:30 a.m. ET. Since the outbreak of the U.S.-Iran conflict in late February, the global energy market has experienced the most severe geopolitical supply shock in history. As the conflict enters its third month, traffic through the Strait of Hormuz remains significantly below pre-war levels, with approximately 20% of the world's oil transit routes still facing "interruption." This inflation report will serve as a critical validation window for the transmission effects of oil prices.

'Big Short' Burry Doubles Down: Nvidia, Palantir Short Positions Double in Big Bet on AI Bubble Bursting

TradingKey — As the Nasdaq continues to hit consecutive record highs, Michael Burry—who rose to fame during the 2008 subprime mortgage crisis and was the inspiration for the film *The Big Short*—is betting with unprecedented intensity on the bursting of the AI bubble.

AMD Q1 Earnings: Data Center Revenue Surges 57% Driving Results Above Estimates, Shares Rise Over 16% After Hours

TradingKey - On May 5 (ET), Advanced Micro Devices (AMD) released its first-quarter fiscal 2026 financial results after the market close. The company reported revenue of $10.253 billion, up 38% year-over-year, exceeding market expectations of $9.89 billion. Non-GAAP earnings per share (EPS) were $1.

Featured Tools